drugset / Trial / NCT05828836
Allopurinol and Quality of Life in Liver Cirrhosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study aims to evaluate the impact of allopurinol on patients' related quality of life.
Timeline
- Start
- 2022-06-15
- Primary completion
- 2023-01-15
- Completion
- 2023-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Allopurinol | Small molecule | 300 mg | — |